# Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura

> **NCT01754545** · PHASE4 · WITHDRAWN · sponsor: **St. Olavs Hospital**

## Conditions studied

- Purpura, Thrombotic Thrombocytopenic

## Interventions

- **DRUG:** Octaplas infusion and placebo (group 1)
- **DRUG:** Octaplas infusion and placebo (group 2)

## Key facts

- **NCT ID:** NCT01754545
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-09
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** altered situation in study population; not enough patients meeting enrollment criteria
- **Last updated:** 2012-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01754545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01754545, "Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01754545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*